Literature DB >> 1427920

VH-gene representation in autoantibodies reflects the normal human B-cell repertoire.

A K Stewart1, C Huang, A A Long, B D Stollar, R S Schwartz.   

Abstract

The recurrence in the V-gene repertoire of individual germline VH genes can now be extended from the restricted B-cell populations of the fetus, autoantibodies and B-cell malignancies to the expressed V-gene repertoire of normal adults. Why the human B cell preferentially utilizes these individual VH genes remains speculative. However, it is apparent that the population of VH genes used to encode autoantibodies reflects the normal expressed repertoire (Fig. 7). Even so, the overrepresentation of other V genes such as Dxp'1 in anti-DNA antibodies and the presence of somatic mutation in the pathogenic autoantibodies of autoimmune disease continues to suggest an antigenic influence on V-gene selection. We postulate that only a fraction of available germline V genes are utilized in the expressed repertoire, and that polyspecificity of naturally occurring antibodies and somatic mutation of CDR3 compensate for the loss of diversity entailed by the limited use of the potential repertoire. The mechanisms by which germline genes become pathogenic remains unclear but they presumably relate to mutation, loss of regulatory control or perhaps environmental factors (Isenberg et al. 1992). What then are the mechanisms which lead to escape of these VH genes from normal control? What antigenic drive if any produces anti-DNA specificity in SLE? Why indeed is the expressed repertoire using only a fraction of the available germline? To answer these questions, further study of the V-gene repertoire of selected populations of antigen-binding cells and of pathogenic IgG autoantibodies is necessary and is ongoing. The contribution of individual V genes to antigen binding and idiotype is also being dissected and promises to yield important information about the relative contribution of VH genes to autoimmunity.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1427920     DOI: 10.1111/j.1600-065x.1992.tb00834.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  24 in total

1.  Chimaeric monoclonal antibodies encoded by the human VH26 gene from naïve transgenic mice display a wide range of antigen-binding specificities.

Authors:  I J Harmer; R A Mageed; A Kaminski; P Charles; M Brüggemann; C G Mackworth-Young
Journal:  Immunology       Date:  1996-06       Impact factor: 7.397

2.  Identification of cation-independent mannose 6-phosphate receptor/insulin-like growth factor type-2 receptor as a novel target of autoantibodies.

Authors:  D Tarrago; I Aguilera; J Melero; I Wichmann; A Nuñez-Roldan; B Sanchez
Journal:  Immunology       Date:  1999-12       Impact factor: 7.397

Review 3.  T-helper cell intrinsic defects in lupus that break peripheral tolerance to nuclear autoantigens.

Authors:  Syamal K Datta; Li Zhang; Luting Xu
Journal:  J Mol Med (Berl)       Date:  2005-01-04       Impact factor: 4.599

Review 4.  T cells of lupus and molecular targets for immunotherapy.

Authors:  S K Datta; A Kaliyaperumal; A Desai-Mehta
Journal:  J Clin Immunol       Date:  1997-01       Impact factor: 8.317

Review 5.  VH-mediated mechanisms in normal and neoplastic B cell development.

Authors:  L E Silberstein; S P Rao
Journal:  Immunol Res       Date:  1998       Impact factor: 2.829

6.  Analysis of the human VH gene repertoire. Differential effects of selection and somatic hypermutation on human peripheral CD5(+)/IgM+ and CD5(-)/IgM+ B cells.

Authors:  H P Brezinschek; S J Foster; R I Brezinschek; T Dörner; R Domiati-Saad; P E Lipsky
Journal:  J Clin Invest       Date:  1997-05-15       Impact factor: 14.808

7.  Clonally-related immunoglobulin VH domains and nonrandom use of DH gene segments in rheumatoid arthritis synovium.

Authors:  B E Clausen; S L Bridges; J C Lavelle; P G Fowler; S Gay; W J Koopman; H W Schroeder
Journal:  Mol Med       Date:  1998-04       Impact factor: 6.354

8.  Comparable profiles of the immunoglobulin heavy chain complementarity determining region (CDR)-3 in CD5+ and CD5- human cord blood B lymphocytes.

Authors:  H Kiyoi; K Naito; R Ohno; T Naoe
Journal:  Immunology       Date:  1995-06       Impact factor: 7.397

9.  Human autoantibody recognition of DNA.

Authors:  S M Barbas; H J Ditzel; E M Salonen; W P Yang; G J Silverman; D R Burton
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

10.  Sequence analysis of immunoglobulin heavy-chain variable region genes from the synovium of a rheumatoid arthritis patient shows little evidence of mutation but diverse CDR3.

Authors:  C M Brown; K J Fitzgerald; S P Moyes; R A Mageed; D G Williams; R N Maini
Journal:  Immunology       Date:  1995-03       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.